Autonomix Medical (AMIX) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T12:05:28.737Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:05:28.737Z.

Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -16,372,000
Quote market capitalization: 1,922,220
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 3,460,000

FMP input reference: a397cd850420951a0c9724a6b76f21fabdb26d17d869f1b33831b183cdf643d3

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

AMIX EBITDA Yield Metrics

EBITDA YIELD

N/A

AMIX Competitors' EBITDA Yield

AMIX

Autonomix Medical, Inc.

Current

Market Cap

$1.92M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRIS

Curis, Inc.

vs AMIX

Market Cap

$1.54M

EBITDA Yield

N/A

TTM Avg

0.69%

3Y Avg

0.69%

5Y Avg

0.69%

ELAB

PMGC Holdings Inc.

vs AMIX

Market Cap

$1.49M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELZ

Creative Medical Technology Holdings, Inc.

vs AMIX

Market Cap

$2.37M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBLG

FibroBiologics, Inc. Common Stock

vs AMIX

Market Cap

$2.47M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARTL

Artelo Biosciences, Inc.

vs AMIX

Market Cap

$1.36M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIAF

bioAffinity Technologies, Inc.

vs AMIX

Market Cap

$2.59M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CMND

Clearmind Medicine Inc.

vs AMIX

Market Cap

$1.11M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ASBP

Aspire Biopharma Holdings, Inc.

vs AMIX

Market Cap

$1.02M

EBITDA Yield

N/A

TTM Avg

86.52%

3Y Avg

86.52%

5Y Avg

86.52%

DCOY

Decoy Therapeutics Inc.

vs AMIX

Market Cap

$888387.00

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Autonomix Medical, Inc. (AMIX)	$1.92M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.54M	N/A	0.69%	0.69%	0.69%
PMGC Holdings Inc. (ELAB)vs ›	$1.49M	N/A	N/A	N/A	N/A
Creative Medical Technology Holdings, Inc. (CELZ)vs ›	$2.37M	N/A	N/A	N/A	N/A
FibroBiologics, Inc. Common Stock (FBLG)vs ›	$2.47M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.36M	N/A	N/A	N/A	N/A
bioAffinity Technologies, Inc. (BIAF)vs ›	$2.59M	N/A	N/A	N/A	N/A
Clearmind Medicine Inc. (CMND)vs ›	$1.11M	N/A	N/A	N/A	N/A
Aspire Biopharma Holdings, Inc. (ASBP)vs ›	$1.02M	N/A	86.52%	86.52%	86.52%
Decoy Therapeutics Inc. (DCOY)vs ›	$888387.00	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

AMIX EBITDA Yield Metrics

AMIX Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics